Annual FCF:
-$232.83M-$47.76M(-25.81%)Summary
- As of today, VRDN annual free cash flow is -$232.83 million, with the most recent change of -$47.76 million (-25.81%) on December 31, 2024.
- During the last 3 years, VRDN annual free cash flow has fallen by -$177.91 million (-323.95%).
- VRDN annual free cash flow is now -19749.10% below its all-time high of -$1.17 million, reached on December 31, 2013.
Performance
VRDN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$75.42M+$17.32M(+18.68%)Summary
- As of today, VRDN quarterly free cash flow is -$75.42 million, with the most recent change of +$17.32 million (+18.68%) on June 30, 2025.
- Over the past year, VRDN quarterly free cash flow has dropped by -$29.25 million (-63.37%).
- VRDN quarterly free cash flow is now -35846.14% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$309.60M-$29.25M(-10.43%)Summary
- As of today, VRDN TTM free cash flow is -$309.60 million, with the most recent change of -$29.25 million (-10.43%) on June 30, 2025.
- Over the past year, VRDN TTM free cash flow has dropped by -$140.78 million (-83.39%).
- VRDN TTM free cash flow is now -147468.64% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
VRDN Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -25.8% | -63.4% | -83.4% |
| 3Y3 Years | -323.9% | -310.4% | -353.4% |
| 5Y5 Years | -544.2% | -1010.8% | -997.8% |
VRDN Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -323.9% | at low | -98.2% | +18.7% | -284.8% | at low |
| 5Y | 5-Year | -680.8% | at low | -1364.9% | +18.7% | -997.8% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | +18.7% | >-9999.0% | at low |
VRDN Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$75.42M(+18.7%) | -$309.60M(-10.4%) |
| Mar 2025 | - | -$92.74M(-26.3%) | -$280.35M(-20.4%) |
| Dec 2024 | -$232.83M(-25.8%) | -$73.45M(-8.0%) | -$232.83M(-17.9%) |
| Sep 2024 | - | -$68.00M(-47.3%) | -$197.43M(-16.9%) |
| Jun 2024 | - | -$46.16M(-2.1%) | -$168.82M(-0.4%) |
| Mar 2024 | - | -$45.22M(-18.9%) | -$168.20M(+9.1%) |
| Dec 2023 | -$185.07M(-95.6%) | -$38.05M(+3.4%) | -$185.07M(-25.9%) |
| Sep 2023 | - | -$39.39M(+13.5%) | -$147.02M(-36.6%) |
| Jun 2023 | - | -$45.55M(+26.6%) | -$107.63M(-33.8%) |
| Mar 2023 | - | -$62.09M(-237.8%) | -$80.47M(-17.8%) |
| Dec 2022 | -$94.64M(-72.3%) | - | - |
| Jun 2022 | - | -$18.38M(+13.4%) | -$68.28M(-5.7%) |
| Mar 2022 | - | -$21.22M(-27.7%) | -$64.59M(-17.6%) |
| Dec 2021 | -$54.92M(-84.2%) | -$16.62M(-37.8%) | -$54.92M(-15.1%) |
| Sep 2021 | - | -$12.06M(+17.9%) | -$47.73M(-16.9%) |
| Jun 2021 | - | -$14.69M(-27.1%) | -$40.81M(-24.0%) |
| Mar 2021 | - | -$11.55M(-22.6%) | -$32.92M(-10.4%) |
| Dec 2020 | -$29.82M(+17.5%) | -$9.43M(-83.1%) | -$29.82M(-5.7%) |
| Sep 2020 | - | -$5.15M(+24.2%) | -$28.20M(+12.8%) |
| Jun 2020 | - | -$6.79M(+19.7%) | -$32.34M(+1.3%) |
| Mar 2020 | - | -$8.46M(-8.4%) | -$32.75M(+9.4%) |
| Dec 2019 | -$36.14M | -$7.81M(+15.9%) | -$36.14M(+1.1%) |
| Sep 2019 | - | -$9.28M(-28.8%) | -$36.56M(-6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$7.21M(+39.2%) | -$34.28M(-8.2%) |
| Mar 2019 | - | -$11.85M(-44.0%) | -$31.68M(-16.1%) |
| Dec 2018 | -$27.29M(+4.0%) | -$8.23M(-17.4%) | -$27.29M(-3.6%) |
| Sep 2018 | - | -$7.01M(-52.3%) | -$26.34M(-5.1%) |
| Jun 2018 | - | -$4.60M(+38.3%) | -$25.06M(+9.3%) |
| Mar 2018 | - | -$7.46M(-2.5%) | -$27.64M(+2.7%) |
| Dec 2017 | -$28.41M(-292.8%) | -$7.28M(-27.1%) | -$28.41M(-16.3%) |
| Sep 2017 | - | -$5.73M(+20.3%) | -$24.43M(+6.7%) |
| Jun 2017 | - | -$7.18M(+12.7%) | -$26.18M(-24.6%) |
| Mar 2017 | - | -$8.23M(-149.5%) | -$21.01M(-40.0%) |
| Dec 2016 | -$7.23M(-3.0%) | -$3.30M(+55.9%) | -$15.01M(-15.2%) |
| Sep 2016 | - | -$7.47M(-272.3%) | -$13.03M(-65.1%) |
| Jun 2016 | - | -$2.01M(+9.8%) | -$7.89M(+2.5%) |
| Mar 2016 | - | -$2.23M(-68.3%) | -$8.09M(-15.3%) |
| Dec 2015 | -$7.02M(-183.2%) | -$1.32M(+43.4%) | -$7.02M(-0.9%) |
| Sep 2015 | - | -$2.34M(-5.7%) | -$6.96M(-27.6%) |
| Jun 2015 | - | -$2.21M(-91.7%) | -$5.45M(-68.2%) |
| Mar 2015 | - | -$1.15M(+8.4%) | -$3.24M(-55.2%) |
| Dec 2014 | -$2.48M(-111.3%) | -$1.26M(-51.4%) | -$2.09M(-75.4%) |
| Sep 2014 | - | -$831.00K(-130.8%) | -$1.19M(-230.8%) |
| Dec 2013 | -$1.17M(+81.5%) | -$360.10K(-71.6%) | -$360.10K(-71.6%) |
| Dec 2012 | -$6.33M | - | - |
| Dec 2012 | - | -$209.80K | -$209.80K |
FAQ
- What is Viridian Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Viridian Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Viridian Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of VRDN is -$232.83M
What is the all-time high annual free cash flow for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual free cash flow is -$1.17M
What is Viridian Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, VRDN annual free cash flow has changed by -$47.76M (-25.81%)
What is Viridian Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of VRDN is -$75.42M
What is the all-time high quarterly free cash flow for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly free cash flow is -$209.80K
What is Viridian Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, VRDN quarterly free cash flow has changed by -$29.25M (-63.37%)
What is Viridian Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of VRDN is -$309.60M
What is the all-time high TTM free cash flow for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM free cash flow is -$209.80K
What is Viridian Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, VRDN TTM free cash flow has changed by -$140.78M (-83.39%)